Unda 13 (Seroyal USA)


Welcome to the PulseAid listing for the Unda 13 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Boldo Leaf, Ricinus communis Seed, Combretum raimbaultii Leaf, Jateorhiza palmata Root, Argentum metallicum
SUBSTANCE NAME: SILVER; PEUMUS BOLDUS LEAF; RICINUS COMMUNIS SEED; COMBRETUM MICRANTHUM LEAF; JATEORHIZA CALUMBA ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-12-17
END MARKETING DATE: 0000-00-00


Unda 13 HUMAN OTC DRUG Details:

Item DescriptionUnda 13 from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 12; 4; 4; 4; 4([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL)
START MARKETING DATE: 2014-12-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1112_0a6be318-a46a-385b-e054-00144ff8d46c
PRODUCT NDC: 62106-1112
APPLICATION NUMBER:

Other SILVER; PEUMUS BOLDUS LEAF; RICINUS COMMUNIS SEED; COMBRETUM MICRANTHUM LEAF; JATEORHIZA CALUMBA ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USAUnda 13